Tower Research Capital (TRC)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Sell |
5,782
-4,684
| -45% | -$257K | 0.01% | 1372 |
|
|
2025
Q1 | $740K | Sell |
10,466
-6,526
| -38% | -$461K | 0.02% | 642 |
|
|
2024
Q4 | $1.12M | Buy |
16,992
+13,426
| +377% | +$882K | 0.02% | 570 |
|
|
2024
Q3 | $251K | Sell |
3,566
-22,232
| -86% | -$1.56M | 0.01% | 1410 |
|
|
2024
Q2 | $2.12M | Buy |
25,798
+25,296
| +5,039% | +$2.08M | 0.04% | 408 |
|
|
2024
Q1 | $43.8K | Sell |
502
-2,996
| -86% | -$262K | ﹤0.01% | 2376 |
|
|
2023
Q4 | $337K | Sell |
3,498
-5,349
| -60% | -$516K | ﹤0.01% | 1684 |
|
|
2023
Q3 | $783K | Sell |
8,847
-3,956
| -31% | -$350K | 0.02% | 642 |
|
|
2023
Q2 | $1.11M | Buy |
12,803
+7,461
| +140% | +$647K | 0.04% | 447 |
|
|
2023
Q1 | $520K | Buy |
5,342
+2,206
| +70% | +$215K | 0.02% | 805 |
|
|
2022
Q4 | $324K | Buy |
3,136
+2,281
| +267% | +$236K | 0.01% | 967 |
|
|
2022
Q3 | $73K | Sell |
855
-9,528
| -92% | -$814K | ﹤0.01% | 2836 |
|
|
2022
Q2 | $861K | Buy |
10,383
+835
| +9% | +$69.2K | 0.02% | 792 |
|
|
2022
Q1 | $736K | Buy |
9,548
+3,447
| +56% | +$266K | 0.01% | 930 |
|
|
2021
Q4 | $539K | Buy |
6,101
+4,664
| +325% | +$412K | 0.01% | 1068 |
|
|
2021
Q3 | $111K | Sell |
1,437
-2,381
| -62% | -$184K | ﹤0.01% | 2310 |
|
|
2021
Q2 | $319K | Sell |
3,818
-19,047
| -83% | -$1.59M | 0.01% | 1550 |
|
|
2021
Q1 | $1.73M | Buy |
22,865
+14,650
| +178% | +$1.11M | 0.03% | 533 |
|
|
2020
Q4 | $721K | Buy |
8,215
+1,995
| +32% | +$175K | 0.02% | 717 |
|
|
2020
Q3 | $473K | Buy |
6,220
+3,719
| +149% | +$283K | 0.01% | 1735 |
|
|
2020
Q2 | $308K | Buy |
+2,501
| New | +$308K | 0.01% | 1420 |
|
|
2020
Q1 | – | Sell |
-114
| Closed | -$10K | – | 3072 |
|
|
2019
Q4 | $10K | Sell |
114
-1,055
| -90% | -$92.5K | ﹤0.01% | 2318 |
|
|
2019
Q3 | $79K | Sell |
1,169
-572
| -33% | -$38.7K | 0.01% | 1491 |
|
|
2019
Q2 | $150K | Buy |
1,741
+1,057
| +155% | +$91.1K | 0.01% | 989 |
|
|
2019
Q1 | $60K | Buy |
684
+589
| +620% | +$51.7K | ﹤0.01% | 1679 |
|
|
2018
Q4 | $8K | Sell |
95
-6,434
| -99% | -$542K | ﹤0.01% | 2609 |
|
|
2018
Q3 | $633K | Buy |
6,529
+2,103
| +48% | +$204K | 0.05% | 380 |
|
|
2018
Q2 | $417K | Buy |
4,426
+2,566
| +138% | +$242K | 0.02% | 725 |
|
|
2018
Q1 | $151K | Sell |
1,860
-1,429
| -43% | -$116K | 0.01% | 1022 |
|
|
2017
Q4 | $293K | Buy |
3,289
+2,134
| +185% | +$190K | 0.04% | 441 |
|
|
2017
Q3 | $107K | Buy |
1,155
+1,123
| +3,509% | +$104K | 0.01% | 1285 |
|
|
2017
Q2 | $3K | Buy |
+32
| New | +$3K | ﹤0.01% | 2182 |
|
|
2017
Q1 | – | Sell |
-23
| Closed | -$2K | – | 3087 |
|
|
2016
Q4 | $2K | Buy |
+23
| New | +$2K | ﹤0.01% | 3383 |
|
|
2016
Q3 | – | Sell |
-2,336
| Closed | -$182K | – | 3661 |
|
|
2016
Q2 | $182K | Buy |
2,336
+1,145
| +96% | +$89.2K | 0.02% | 722 |
|
|
2016
Q1 | $99K | Buy |
1,191
+942
| +378% | +$78.3K | 0.01% | 507 |
|
|
2015
Q4 | $26K | Sell |
249
-494
| -66% | -$51.6K | ﹤0.01% | 1009 |
|
|
2015
Q3 | $78K | Sell |
743
-812
| -52% | -$85.2K | 0.01% | 716 |
|
|
2015
Q2 | $213K | Sell |
1,555
-2,494
| -62% | -$342K | 0.02% | 336 |
|
|
2015
Q1 | $505K | Buy |
4,049
+2,360
| +140% | +$294K | 0.06% | 172 |
|
|
2014
Q4 | $153K | Buy |
1,689
+1,667
| +7,577% | +$151K | 0.01% | 402 |
|
|
2014
Q3 | $2K | Sell |
22
-1,184
| -98% | -$108K | ﹤0.01% | 3776 |
|
|
2014
Q2 | $75K | Sell |
1,206
-2,780
| -70% | -$173K | 0.01% | 1046 |
|
|
2014
Q1 | $272K | Sell |
3,986
-412
| -9% | -$28.1K | 0.03% | 328 |
|
|
2013
Q4 | $310K | Buy |
4,398
+1,923
| +78% | +$136K | 0.05% | 331 |
|
|
2013
Q3 | $179K | Buy |
2,475
+747
| +43% | +$54K | 0.02% | 825 |
|
|
2013
Q2 | $96K | Buy |
+1,728
| New | +$96K | 0.01% | 519 |
|